$515 Million is the total value of Samsara BioCapital, LLC's 51 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 6.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GRPH | Buy | GRAPHITE BIO INC | $97,600,000 | -19.9% | 7,851,933 | +5.7% | 18.94% | -0.9% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $74,894,000 | +73.8% | 4,591,888 | +36.0% | 14.53% | +114.9% |
| TIL | Sell | INSTIL BIO INC | $34,082,000 | -11.1% | 1,991,950 | -7.2% | 6.61% | +9.9% |
| NKTX | NKARTA INC | $31,233,000 | -44.8% | 2,034,703 | 0.0% | 6.06% | -31.8% | |
| STRO | SUTRO BIOPHARMA INC | $24,933,000 | -21.2% | 1,675,579 | 0.0% | 4.84% | -2.6% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $22,262,000 | -38.7% | 1,565,526 | 0.0% | 4.32% | -24.2% | |
| ISEE | Sell | IVERIC BIO INC | $21,110,000 | -11.1% | 1,262,551 | -13.7% | 4.10% | +9.9% |
| RAIN | RAIN THERAPEUTICS INC | $20,239,000 | -13.9% | 1,571,379 | 0.0% | 3.93% | +6.5% | |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $16,436,000 | -36.0% | 1,459,693 | -5.1% | 3.19% | -20.8% |
| NVAX | NOVAVAX INCcall | $11,818,000 | -31.0% | 82,600 | 0.0% | 2.29% | -14.7% | |
| ACRS | ACLARIS THERAPEUTICS INC | $11,547,000 | -19.2% | 794,171 | 0.0% | 2.24% | -0.1% | |
| New | SCIENCE 37 HOLDINGS INC | $11,223,000 | – | 900,000 | +100.0% | 2.18% | – | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $10,437,000 | +9.7% | 640,688 | 0.0% | 2.02% | +35.6% | |
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $9,237,000 | -46.7% | 539,236 | -28.4% | 1.79% | -34.1% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $8,694,000 | -19.3% | 140,267 | -17.4% | 1.69% | -0.2% |
| JANX | JANUX THERAPEUTICS INC | $8,126,000 | -8.8% | 411,871 | 0.0% | 1.58% | +12.7% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $7,467,000 | +22.6% | 1,111,112 | 0.0% | 1.45% | +51.7% | |
| New | IO BIOTECH INC | $7,171,000 | – | 1,120,437 | +100.0% | 1.39% | – | |
| Sell | TANGO THERAPEUTICS INC | $6,892,000 | -23.9% | 630,000 | -10.0% | 1.34% | -5.8% | |
| SYRS | SYROS PHARMACEUTICALS INC | $6,243,000 | -27.6% | 2,189,199 | 0.0% | 1.21% | -10.5% | |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $5,875,000 | +25.3% | 480,000 | +6.7% | 1.14% | +54.9% |
| ELEV | ELEVATION ONCOLOGY INC | $5,612,000 | -22.7% | 932,240 | 0.0% | 1.09% | -4.4% | |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $5,328,000 | -1.0% | 659,409 | +20.1% | 1.03% | +22.4% |
| JYAC | JIYA ACQUISITION CORP | $4,954,000 | +0.2% | 507,041 | 0.0% | 0.96% | +23.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $4,198,000 | -40.3% | 883,720 | 0.0% | 0.81% | -26.1% | |
| NVAX | Sell | NOVAVAX INC | $3,883,000 | -37.9% | 27,144 | -10.0% | 0.75% | -23.2% |
| DBTX | DECIBEL THERAPEUTICS INC | $3,843,000 | -39.7% | 826,422 | 0.0% | 0.75% | -25.4% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $3,614,000 | -61.3% | 737,459 | 0.0% | 0.70% | -52.1% | |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $3,446,000 | -12.1% | 345,293 | +15.0% | 0.67% | +8.8% |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $3,412,000 | -29.0% | 202,500 | 0.0% | 0.66% | -12.2% | |
| BLSA | BCLS ACQUISITION CORP | $2,940,000 | -1.6% | 300,000 | 0.0% | 0.57% | +21.5% | |
| VIRX | VIRACTA THERAPEUTICS INC | $2,595,000 | -54.5% | 711,039 | 0.0% | 0.50% | -43.8% | |
| ALBO | ALBIREO PHARMA INC | $2,329,000 | -25.4% | 100,000 | 0.0% | 0.45% | -7.8% | |
| EQ | Sell | EQUILLIUM INC | $2,321,000 | -53.9% | 615,541 | -16.6% | 0.45% | -43.0% |
| IMCR | IMMUNOCORE HLDGS PLCads | $2,191,000 | -7.6% | 64,000 | 0.0% | 0.42% | +14.2% | |
| TERN | TERNS PHARMACEUTICALS INC | $2,044,000 | -32.1% | 289,068 | 0.0% | 0.40% | -16.1% | |
| SURROZEN INC | $1,932,000 | -9.0% | 300,000 | 0.0% | 0.38% | +12.6% | ||
| ALLK | ALLAKOS INC | $1,685,000 | -90.8% | 172,089 | 0.0% | 0.33% | -88.6% | |
| ALLK | ALLAKOS INCcall | $1,647,000 | -90.8% | 168,200 | 0.0% | 0.32% | -88.5% | |
| VTVT | New | VTV THERAPEUTICS INCcl a | $1,627,000 | – | 1,635,509 | +100.0% | 0.32% | – |
| BCEL | ATRECA INC | $1,202,000 | -51.4% | 396,835 | 0.0% | 0.23% | -39.9% | |
| ALVR | ALLOVIR INC | $1,065,000 | -48.4% | 82,336 | 0.0% | 0.21% | -36.1% | |
| KRON | KRONOS BIO INC | $1,062,000 | -35.2% | 78,131 | 0.0% | 0.21% | -19.8% | |
| BNTX | Sell | BIONTECH SEsponsored ads | $1,039,000 | -33.9% | 4,031 | -30.0% | 0.20% | -18.2% |
| VTGN | VISTAGEN THERAPEUTICS INC | $953,000 | -28.8% | 488,632 | 0.0% | 0.18% | -11.9% | |
| ODT | ODONATE THERAPEUTICS INC | $946,000 | -53.6% | 700,421 | 0.0% | 0.18% | -42.5% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $885,000 | -27.0% | 40,550 | 0.0% | 0.17% | -9.5% | |
| KALA | KALA PHARMACEUTICALS INC | $727,000 | -53.8% | 601,162 | 0.0% | 0.14% | -42.9% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $242,000 | -15.7% | 13,669 | 0.0% | 0.05% | +4.4% | |
| ASTRIA THERAPEUTICS INC | $135,000 | -38.9% | 25,000 | 0.0% | 0.03% | -25.7% | ||
| AMRN | AMARIN CORP PLCspons adr new | $84,000 | -34.4% | 25,000 | 0.0% | 0.02% | -20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.